Chelation therapy in beta-thalassemia: The benefits and limitations of desferrioxamine

Author(s): Grady, R. W.

Journal/Book: Semin Hematol. 1995; 32: Independence Square West, Curtis Center, Ste 300, Philadelphia, PA 19106-3399. W B Saunders Co. 304-312.

Note: Article PJ Giardina, Cornell Univ, Med Ctr, Dept Pediat, Div Pediat Hematol Oncol, Room N-740, 525 E 68TH St, New York, NY 10021 USA

Keyword(s): AMBULATORY INTRAVENOUS DEFEROXAMINE; SUBCUTANEOUS DEFEROXAMINE; IRON CHELATION; AUDITORY NEUROTOXICITY; PULMONARY-FUNCTION; OCULAR TOXICITY; RENAL-FUNCTION; COOLEY ANEMIA; ABNORMALITIES; OVERLOAD

Zurück | Weiter